BRIP1/FANCJ Antibody (27F4)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26474
Recombinant monoclonal antibody expressed in HEK293F cells
Key Product Details
Species Reactivity
Human
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 27F4
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthesized peptide derived from Human BRIP1/FANCJ [UniProt Q9BX63]
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for BRIP1/FANCJ Antibody (27F4)
Western Blot: BRIP1/FANCJ Antibody (27F4) [NBP3-26474] -
Western Blot: BRIP1/FANCJ Antibody (27F4) [NBP3-26474] - Positive Western Blot detected in: MCF7 whole cell lysate, HEPG2 whole cell lysate.All lanes: BRIP1/FANCJ Antibody at 1: 1000
Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution.
Predicted band size: 105 kDa
Observed band size: 105 kDa
Applications for BRIP1/FANCJ Antibody (27F4)
Application
Recommended Usage
Western Blot
1:500-1:2000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.4, 150mM NaCl and 50% glycerol
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20 to -70C. Avoid freeze-thaw cycles.
Background: BRIP1/FANCJ
FANCG antibodies are useful for DNA repair studies and cell cycle research.
Long Name
BRCA1 Interacting Protein C-terminal Helicase 1
Alternate Names
BACH1, FACJ, FANCJ
Gene Symbol
BRIP1
Additional BRIP1/FANCJ Products
Product Documents for BRIP1/FANCJ Antibody (27F4)
Product Specific Notices for BRIP1/FANCJ Antibody (27F4)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...